FrancophonIA/ELRC3.0 huggingface dataset:
English: In fertility studies in rats, semaglutide did not affect mating performance or male fertility.
Croatian: Ispitivanja plodnosti u štakora pokazala su da semaglutid nije utjecao na reproduktivno ponašanje ni na plodnost mužjaka.
English: At week 40, the increase in pulse rate for Ozempic (0.5 mg and 1 mg) and dulaglutide (0.75 mg and 1.5 mg) was 2.4, 4.0, and 1.6, 2.1, beats/min, respectively.
Croatian: U 40. tjednu, povećanje pulsa za Ozempic (0,5 mg i 1 mg) i dulaglutid (0,75 mg i 1,5 mg) iznosilo je 2,4; 4,0 otkucaja/min odnosno 1,6; 2,1 otkucaja/min.
English: In patients with type 2 diabetes, treatment with semaglutide 1 mg resulted in reductions in glucose in terms of absolute change from baseline (mmol/L) and relative reduction compared to placebo (%) for fasting glucose (1.6 mmol/L; 22% reduction), 2 hour postprandial glucose (4.1 mmol/L; 37% reduction), mean 24 hour glucose concentration (1.7 mmol/L; 22% reduction) and postprandial glucose excursions over 3 meals (0.6-1.1 mmol/L) compared with placebo.
Croatian: U bolesnika sa šećernom bolešću tipa 2 liječenje semaglutidom 1 mg rezultiralo je smanjenjem glukoze u smislu apsolutne promjene od početne vrijednosti (mmol/l) i relativno smanjenje u usporedbi s placebom (%) za glukozu natašte (1,6 mmol/l; smanjenje 22%), postprandijalne glukoze nakon 2 sata (4,1 mmol/l; smanjenje 37%), srednju vrijednost koncentracije glukoze tijekom 24 sata (1,7 mmol/l; smanjenje 22%) i odstupanja u razinama postprandijalne glukoze tijekom 3 obroka (0,6-1,1 mmol/l) u usporedbi s placebom.
English: What you need to know before you use Ozempic Do not use Ozempic:
Croatian: Što morate znati prije nego počnete primjenjivati Ozempic
English: After 4 weeks the dose should be increased to 0.5 mg once weekly.
Croatian: Nakon 4 tjedna dozu treba povećati na 0,5 mg jedanput na tjedan.
English: The pharmacokinetics of semaglutide were evaluated in patients with different degrees of hepatic impairment (mild, moderate, severe) compared with subjects with normal hepatic function in a study with a single-dose of 0.5 mg semaglutide.
Croatian: Farmakokinetika semaglutida za bolesnike procijenjena je u bolesnika s različitim stupnjevima oštećenja funkcije jetre (blago, umjereno, teško) u usporedbi s ispitanicima s normalnom funkcijom jetre u ispitivanju s jednom dozom od 0,5 mg semaglutida.
English: In patients with diabetic retinopathy treated with insulin and semaglutide, an increased risk of developing diabetic retinopathy complications has been observed (see section 4.8).
Croatian: U bolesnika s dijabetičkom retinopatijom liječenih inzulinom i semaglutidom zabilježen je povećani rizik od komplikacija dijabetičke retinopatije (vidjeti dio 4.8).
English: Figure 2 Mean change in HbA1c (%) and body weight (kg) from baseline to week 40
Croatian: Slika 2 Srednja vrijednost promjene HbA1c (%) i tjelesne težine (kg) od početne vrijednosti do 40. tjedna
English: Figure 1 Mean change in HbA1c (%) and body weight (kg) from baseline to week 56
Croatian: Slika 1 Srednja vrijednost promjene HbA1c (%) i tjelesne težine (kg) od početne vrijednosti do 56. tjedna
English: The primary endpoint was time from randomisation to first occurrence of a major adverse cardiovascular event (MACE): cardiovascular death, non-fatal myocardial infarction or non-fatal stroke.
Croatian: Primarna mjera ishoda bilo je vrijeme od randomizacije do prvog nastupa bilo kojeg velikog kardiovaskularnog štetnog događaja (engl. major adverse cardiovascular events, MACE): smrti uzrokovane kardiovaskularnim događajem, infarkta miokarda bez smrtnog ishoda ili moždanog udara bez smrtnog ishoda.
English: Semaglutide did not change the overall exposure of atorvastatin following a single dose administration of atorvastatin (40 mg).
Croatian: Semaglutid nije promijenio ukupnu izloženost atorvastatinu nakon primjene jedne doze atorvastatina (40 mg).
English: The 0 must line up with the dose pointer.
Croatian: Znamenka 0 se mora poravnati s pokazivačem doze.
English: If you stop using Ozempic
Croatian: Ako prestanete primjenjivati Ozempic
English: Hepatic impairment did not have any impact on the exposure of semaglutide.
Croatian: Oštećenje jetre nije imalo nikakav utjecaj na izloženost semaglutidu.
English: Change from baseline at week 56
Croatian: Promjena od početne vrijednosti u 56. tjednu
English: Semaglutide 1 mg
Croatian: Semaglutid 1 mg
English: Compared to placebo, semaglutide improved first- and second-phase insulin response with a 3- and 2-fold increase, respectively, and increased maximal beta-cell secretory capacity in patients with type 2 diabetes.
Croatian: U usporedbi s placebom semaglutid je trostruko odnosno dvostruko poboljšao prvu i drugu fazu inzulinskog odgovora te je povećao maksimalni kapacitet lučenja beta stanica u bolesnika sa šećernom bolešću tipa
English: 1 pen and 4 disposable needles (4 doses) 3 pens and 12 disposable needles (12 doses)
Croatian: 1 brizgalica i 4 jednokratne igle (4 doze) 3 brizgalice i 12 jednokratnih igala (12 doza)
English: In a 56-week active-controlled double-blind trial, 1,231 patients were randomised to Ozempic 0.5 mg once weekly, Ozempic 1 mg once weekly or sitagliptin 100 mg once daily, all in combination with metformin (94%) and/or thiazolidinediones (6%).
Croatian: U 56-tjednom aktivno kontroliranom dvostruko slijepom ispitivanju, 1231 bolesnik randomiziran je na Ozempic 0,5 mg jedanput na tjedan, Ozempic 1 mg jedanput na tjedan ili sitagliptin 100 mg jedanput na dan, svi u kombinaciji s metforminom (94%) i/ili tiazolidindionom (6%).
English: In patients with type 2 diabetes clearance of semaglutide was approximately 0.05 L/h.
Croatian: U bolesnika sa šećernom bolešću tipa 2 klirens semaglutida bio je približno 0,05 l/h.
English: In a 104-week double-blind trial (SUSTAIN 6), 3,297 patients with type 2 diabetes mellitus at high cardiovascular risk were randomised to either Ozempic 0.5 mg once weekly, Ozempic 1 mg once weekly or corresponding placebo in addition to standard-of-care hereafter followed for 2 years.
Croatian: U 104-tjednom dvostruko slijepom ispitivanju (SUSTAIN 6), 3297 bolesnika sa šećernom bolešću tipa 2 i visokim kardiovaskularnim rizikom randomizirano je na Ozempic 0,5 mg jedanput na tjedan, Ozempic 1 mg jedanput na tjedan ili odgovarajući placebo kao dodatak standardnom liječenju, a zatim su praćeni tijekom 2 godine.
English: Talk to your doctor, pharmacist or nurse before using this medicine.
Croatian: Upozorenja i mjere opreza Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego primijenite ovaj lijek.
English: Diabetic retinopathy complications is a composite of: retinal photocoagulation, treatment with intravitreal agents, vitreous haemorrhage, diabetes-related blindness (uncommon).
Croatian: Komplikacije dijabetičke retinopatije uključuje sljedeće: retinalnu fotokoagulaciju, liječenje intravitrealnim lijekovima, krvarenje vitreusa, sljepoću povezanu sa šećernom bolešću (manje često).
English: When it is used in combination with a sulfonylurea or insulin, patients should be advised to take precautions to avoid hypoglycaemia while driving and using machines (see section 4.4).
Croatian: Kada se primjenjuje u kombinaciji sa sulfonilurejom ili inzulinom, bolesnike treba savjetovati da poduzmu mjere opreza kako bi izbjegli hipoglikemiju tijekom vožnje i rada sa strojevima (vidjeti dio
English: No dose adjustment is required for patients with hepatic impairment.
Croatian: Nije potrebno prilagođavati dozu u bolesnika s oštećenjem jetre.
English: SUSTAIN 2 - Ozempic vs. sitagliptin both in combination with 1-2 oral antidiabetic drugs (metformin and/or thiazolidinediones)
Croatian: SUSTAIN 2 - Ozempic naspram sitagliptin oba u kombinaciji s 1-2 oralna antidijabetika (metformin i/ili tiazolidindion)
English: 1 mg selected
Croatian: odabran 1 mg
English: One ml solution for injection contains 1.34 mg semaglutide.
Croatian: Jedan ml otopine za injekciju sadrži 1,34 mg semaglutida.
English: Experience with the use of semaglutide in patients with severe renal impairment is limited.
Croatian: Iskustvo s primjenom semaglutida u bolesnika s teškim oštećenjem bubrega je ograničeno.
English: • Turn the dose selector to select 1 mg.
Croatian: • Okrenite izbornik doze kako bi odabrali dozu od 1 mg.
English: However, when initiating treatment with Ozempic in combination with a sulfonylurea or an insulin, blood glucose self-monitoring may become necessary to adjust the dose of the sulfonylurea or the insulin to reduce the risk of hypoglycaemia (see section 4.4).
Croatian: Međutim, kad se započinje liječenje lijekom Ozempic u kombinaciji sa sulfonilurejom ili inzulinom, samopraćenje glukoze u krvi može biti potrebno radi prilagođavanja doze sulfonilureje ili inzulina kako bi se smanjio rizik od hipoglikemije (vidjeti dio 4.4).
English: SUSTAIN 3 - Ozempic vs. exenatide ER both in combination with metformin or metformin with sulfonylurea
Croatian: SUSTAIN 3 - Ozempic naspram eksenatid ER oba u kombinaciji s metforminom ili metforminom sa sulfonilurejom
English: With semaglutide, the insulin secretion rate in patients with type 2 diabetes was comparable to that of healthy subjects.
Croatian: Kod semaglutida brzina izlučivanja inzulina u bolesnika sa šećernom bolešću tipa 2 bila je usporediva s onom zdravih ispitanika.
English: Semaglutide delays gastric emptying and has the potential to impact the rate of absorption of concomitantly administered oral medicinal products.
Croatian: Semaglutid odgađa pražnjenje želuca i može utjecati na brzinu apsorpcije istodobno primijenjenih peroralnih lijekova.
English: Effects on the digestive system
Croatian: Učinci na probavni sustav
English: Gastrointestinal disorders were the most frequent adverse events, and occurred in similar proportion of patients receiving Ozempic 0.5 mg (129 patients [43%]), Ozempic 1 mg (133 [44%]), and dulaglutide 1.5 mg (143 [48%]); fewer patients had gastrointestinal disorders with dulaglutide 0.75 mg (100
Croatian: Gastrointestinalni poremećaji bili su najčešće nuspojave, a pojavili su se u sličnom udjelu bolesnika liječenih lijekovima Ozempic 0,5 mg (129 bolesnika [43%]), Ozempic 1 mg (133 bolesnika [44%]) i dulaglutid 1,5 mg (143 bolesnika [48%]).
English: Treatment with semaglutide resulted in a 26% risk reduction in the primary composite outcome of death from cardiovascular causes, non-fatal myocardial infarction or non-fatal stroke.
Croatian: Liječenje semaglutidom rezultiralo je 26-postotnim smanjenjem rizika primarnog kompozitnog ishoda smrti od kardiovaskularnih uzroka, infarkta miokarda bez smrtnog ishoda ili moždanog udara bez smrtnog ishoda.
English: LIST OF EXCIPIENTS disodium phosphate dihydrate, propylene glycol, phenol, hydrochloric acid/sodium hydroxide (for pH adjustment), water for injections
Croatian: POPIS POMOĆNIH TVARI natrijev hidrogenfosfat dihidrat, propilenglikol, fenol, kloridna kiselina/natrijev hidroksid (za podešavanje pH), voda za injekcije
English: Semaglutide did not change the overall exposure or Cmax of digoxin following a single dose of digoxin (0.5 mg).
Croatian: Semaglutid nije promijenio ukupnu izloženost ili Cmax digoksina nakon primjene jedne doze digoksina (0,5 mg).
English: Hypoglycaemiaa when used with insulin or sulfonylurea
Croatian: Hipoglikemijaa kod primjene s inzulinom ili sulfonilurejom
English: An additional trial including 1,201 patients was conducted to compare the efficacy and safety of Ozempic 0.5 mg and 1 mg once weekly to dulaglutide 0.75 mg and 1.5 mg once weekly, respectively.
Croatian: Provedeno je dodatno ispitivanje koje je uključivalo 1201 bolesnika, kako bi se usporedila djelotvornost i sigurnost lijeka Ozempic 0,5 mg naspram dulaglutida 0,75 mg oba jedanput na tjedan i Ozempic 1 mg naspram dulaglutida 1,5 mg oba jedanput na tjedan.
English: In a 30-week double-blind placebo-controlled trial, 388 patients inadequately controlled with diet and exercise, were randomised to Ozempic 0.5 mg or Ozempic 1 mg once weekly or placebo.
Croatian: U 30-tjednom dvostruko slijepom placebom kontroliranom ispitivanju, 388 bolesnika koji nisu odgovarajuće kontrolirani prehranom i vježbom randomizirani su na Ozempic 0,5 mg ili Ozempic 1 mg jedanput tjedno ili placebo.
English: In the 40-week trial versus dulaglutide a weight loss of ≥5% and ≥10% was achieved for more subjects with Ozempic 0.5 mg (44% and 14%) compared with dulaglutide 0.75 mg (23% and 3%) and Ozempic 1 mg (up to 63% and 27%) compared with dulaglutide 1.5 mg (30% and 8%).
Croatian: U 40-tjednom ispitivanju uspoređujući dulaglutid, smanjenje tjelesne težine od ≥5% i ≥10% postiglo je više ispitanika koji su primali Ozempic 0,5 mg (44% i 14%) u usporedbi s dulaglutidom 0,75 mg (23% i 3%) te Ozempic 1 mg (do 63% i 27%) u usporedbi s dulaglutidom 1,5 mg (30% i 8%).
English: When Ozempic is added to existing therapy of sulfonylurea or insulin, a reduction in the dose of sulfonylurea or insulin should be considered to reduce the risk of hypoglycaemia (see sections 4.4 and
Croatian: Kad se Ozempic dodaje postojećem liječenju sulfonilurejom ili inzulinom, treba razmotriti smanjenje doze sulfonilureje ili inzulina kako bi se smanjio rizik od hipoglikemije (vidjeti dijelove 4.4 i 4.8).
English: Fasting and postprandial glucose
Croatian: Glukoza natašte i postprandijalno
English: In a 30-week open-label comparator trial 1,089 patients were randomised to Ozempic 0.5 mg once weekly, Ozempic 1 mg once weekly, or insulin glargine once-daily on a background of metformin (48%) or metformin and sulfonylurea (51%).
Croatian: U 30-tjednom otvorenom usporednom ispitivanju, 1089 bolesnika randomizirano je na Ozempic 0,5 mg jedanput na tjedan, Ozempic 1 mg jedanput na tjedan ili glargin inzulin jedanput na dan u kombinaciji s metforminom (48%) ili metforminom i sulfonilurejom (51%).
English: 0.25 mg selected
Croatian: odabrano 0,25 mg
English: 1 mg in the dose counter must line up precisely with the dose pointer to ensure that you get a correct dose.
Croatian: 1 mg na brojčaniku doze mora se točno poravnati s pokazivačem doze kako bi se osiguralo da dobijete ispravnu dozu.
English: Ask your doctor, nurse or pharmacist about sharps disposal.
Croatian: Obratite se svom liječniku, medicinskoj sestri ili ljekarniku ako imate pitanja o odlaganju oštrih dijelova.
English: SUSTAIN 7 - Ozempic vs. dulaglutide both in combination with metformin In a 40-week, open-label trial, 1,201 patients on metformin were randomised 1:1:1:1 to once weekly Ozempic 0.5 mg, dulaglutide 0.75 mg , Ozempic 1 mg or dulaglutide 1.5 mg, respectively.
Croatian: SUSTAIN 7 - Ozempic naspram dulaglutid oba u kombinaciji s metforminom U 40-tjednom otvorenom ispitivanju, 1201 bolesnik na metforminu randomizirani su 1:1:1:1, Ozempic 0,5 mg jedanput na tjedan, dulaglutid 0,75 mg jedanput na tjedan, Ozempic 1 mg jedanput na tjedan ili dulaglutid 1,5 mg jedanput na tjedan.
English: SUSTAIN 4 - Ozempic vs. insulin glargine both in combination with 1-2 oral antidiabetic drugs (metformin or metformin and sulfonylurea)
Croatian: SUSTAIN 4 - Ozempic naspram glargin inzulin oba u kombinaciji s 1-2 oralna antidijabetika (metformin ili metformin i sulfonilureja)
English: In the phase 3a trials, mean increases of 1 to 6 beats per minute (bpm) from a baseline of 72 to 76 bpm were observed in subjects treated with Ozempic.
Croatian: U ispitivanjima faze 3a, u ispitanika liječenih lijekom Ozempic primijećena je srednja vrijednost porasta srčane frekvencije za 1 do 6 otkucaja u minuti (engl. beat per minute, bpm) u odnosu na početnu vrijednost od 72 do 76 bpm.
English: 1 pen and 4 disposable needles (4 doses)
Croatian: 1 brizgalica i 4 jednokratne igle (4 doze)
English: When the pen is to be disposed of, do it without a needle on as instructed by your doctor, nurse, pharmacist or local authorities.
Croatian: Kad je potrebno zbrinuti brizgalicu, bacite je u otpad bez nataknute igle, sukladno uputama Vašeg liječnika, medicinske sestre, ljekarnika ili u skladu s lokalnim propisima.
English: • When you are not using the pen, keep the pen cap on in order to protect from light.
Croatian: • Kad brizgalicu ne koristite, zatvorite je zatvaračem brizgalice radi zaštite od svjetlosti.
English: Always remove the injection needle after each injection and store the pen without a needle attached.
Croatian: Nakon svakog injiciranja uvijek skinite iglu za injekciju i spremite brizgalicu bez pričvršćene igle.
English: Semaglutide 0.5 mg
Croatian: Semaglutid 0,5 mg
English: • Turn the dose selector to select 0.25 mg.
Croatian: • Okrenite izbornik doze kako bi odabrali dozu od 0,25 mg.
English: Ozempic is to be injected subcutaneously in the abdomen, in the thigh or in the upper arm.
Croatian: Ozempic se primjenjuje supkutanom injekcijom u abdomen, bedro ili nadlakticu.
English: Diabetic retinopathy complicationsb
Croatian: Komplikacije dijabetičke retinopatije b
English: Cardiovascular death Non-fatal stroke Non-fatal myocardial infarction
Croatian: Smrt uzrokovana kardiovaskularnim događajem Moždani udar bez smrtnog ishoda Infarkt miokarda bez smrtnog ishoda
English: A significant and sustained reduction in body weight from baseline to week 104 was observed with Ozempic 0.5 mg and 1 mg vs placebo 0.5 mg and 1 mg, in addition to standard-of-care (-3.6 kg and -4.9 kg vs -0.7 kg and -0.5 kg , respectively) in SUSTAIN 6.
Croatian: U ispitivanju SUSTAIN-6 zabilježeno je značajno i održano smanjenje tjelesne težine od početnih vrijednosti do 104. tjedna s lijekom Ozempic 0,5 mg i 1 mg (-3,6 kg i -4,9 kg) u odnosu na placebo od 0,5 mg i 1 mg (-0,7 kg i -0,5 kg), kao dodatak standardnom liječenju.
English: 0.5 mg in the dose counter must line up precisely with the dose pointer to ensure that you get a correct dose.
Croatian: 0,5 mg na brojčaniku doze mora se točno poravnati s pokazivačem doze kako bi se osiguralo da dobijete ispravnu dozu.
English: 0.25 mg in the dose counter must line up precisely with the dose pointer to ensure that you get a correct dose.
Croatian: 0,25 mg na brojčaniku doze mora se točno poravnati s pokazivačem doze kako bi se osiguralo da dobijete ispravnu dozu.
English: It contains 4 mg of semaglutide, and you can only select doses of 1 mg.
Croatian: Sadrži 4 mg semaglutida i možete odabrati doze od 1 mg.
English: Semaglutide reduces blood glucose in a glucose dependent manner by stimulating insulin secretion and lowering glucagon secretion when blood glucose is high.
Croatian: Semaglutid snižava glukozu u krvi u ovisnosti od glukoze poticanjem lučenja inzulina i snižavanjem lučenja glukagona kad je glukoza u krvi visoka.
English: Semaglutide had a beneficial effect on plasma lipids, lowered systolic blood pressure and reduced inflammation in clinical studies.
Croatian: U kliničkim ispitivanjima semaglutid je imao povoljan učinak na lipide u plazmi, snizio je sistolički krvni tlak i smanjio upalu.
English: INFORMATION IN BRAILLE Ozempic 0.25 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Ozempic 0,25 mg
English: It contains 2 mg of semaglutide, and you can only select doses of 0.25 mg.
Croatian: Sadrži 2 mg semaglutida i možete odabrati samo doze od 0,25 mg.
English: Semaglutide caused a minor delay of early postprandial gastric emptying, thereby reducing the rate at which glucose appears in the circulation postprandially.
Croatian: Semaglutid je uzrokovao blago odgođeno rano postprandijalno pražnjenje želuca, čime se smanjuje brzina postprandijalne pojave glukoze u krvotoku.
English: Keep turning until the dose counter stops and shows 1 mg.
Croatian: Okrećite izbornik doze sve dok se brojčanik doze ne zaustavi i pokaže 1 mg.
English: • Turn the dose selector to select 0.5 mg.
Croatian: • Okrenite izbornik doze kako bi odabrali dozu od 0,5 mg.
English: It contains 2 mg of semaglutide, and you can only select doses of 0.5 mg.
Croatian: Sadrži 2 mg semaglutida i možete odabrati samo doze od 0,5 mg.
English: After your injection
Croatian: 5. Nakon injiciranja
English: • stomach pain
Croatian: • nadutost trbuha
English: One ml of solution contains 1.34 mg of semaglutide*.
Croatian: Jedan ml otopine sadrži 1,34 mg semaglutida*.
English: 1 pre-filled pen and 4 disposable NovoFine Plus needles 3 pre-filled pens and 12 disposable NovoFine Plus needles
Croatian: 1 napunjena brizgalica i 4 jednokratne igle NovoFine Plus 3 napunjene brizgalice i 12 jednokratnih igala NovoFine Plus
English: • Make sure you can see the dose counter.
Croatian: • Provjerite da li je brojčanik doze vidljiv.
English: Combining a sulfonylurea or an insulin with this medicine might increase the risk of getting low blood sugar levels (hypoglycaemia).
Croatian: Primjena ovog lijeka zajedno sa sulfonilurejom ili inzulinom može povećati rizik pojave niske razine šećera u krvi (hipoglikemija).
English: There is no experience in patients with congestive heart failure NYHA class IV and semaglutide is therefore not recommended in these patients.
Croatian: New York Heart Association) klasifikaciji pa se stoga primjena semaglutida ne preporučuje u tih bolesnika.
English: For use by one person only.
Croatian: Lijek smije primjenjivati samo jedna osoba.
English: Increased heart rate has been observed with GLP-1 receptor agonists.
Croatian: Povećana srčana frekvencija primijećena je kod agonista receptora GLP-1.
English: Change from baseline at week 30
Croatian: Promjena od početne vrijednosti u 30. tjednu
English: • bloating of the stomach
Croatian: • bol u trbuhu
English: This may prevent blocked needles, contamination, infection, leakage of solution and inaccurate dosing.
Croatian: Time možete spriječiti začepljenje igala, onečišćenje, infekciju, istjecanje otopine i neispravno doziranje.
English: Ozempic 1 mg solution for injection: Each pre-filled pen contains 3 ml of solution, delivering 4 doses of 1 mg.
Croatian: Ozempic 1 mg otopina za injekciju: Jedna napunjena brizgalica sadrži 3 ml otopine, za primjenu 4 doze od 1 mg.
English: The trial compared 0.5 mg of Ozempic to 0.75 mg of dulaglutide and 1 mg of Ozempic to 1.5 mg of dulaglutide.
Croatian: Ispitivanje je uspoređivalo Ozempic 0,5 mg s dulaglutidom 0,75 mg te Ozempic 1 mg s dulaglutidom 1,5 mg.
English: When to use Ozempic
Croatian: Kada primjenjivati Ozempic
English: Increased lipase Increased amylase Weight decreased a)
Croatian: Smanjenje težine a)
English: INFORMATION IN BRAILLE Ozempic 1 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Ozempic 1 mg
English: This reduces the risk of blocked needles, contamination, infection and inaccurate dosing.
Croatian: Tako se smanjuje rizik od začepljenja igala, onečišćenja, infekcije i netočnog doziranja.
English: Flow check symbol
Croatian: Simbol za provjeru protoka
English: Start by checking your pen to make sure that it contains Ozempic 0.25 mg, then look at the illustrations below to get to know the different parts of your pen and needle.
Croatian: Započnite tako što ćete provjeriti Vašu brizgalicu kako biste bili sigurni da sadrži Ozempic 0,25 mg, zatim pogledajte ilustracije u nastavku da se upoznate s različitim dijelovima Vaše brizgalice i igle.
English: NAME OF THE MEDICINAL PRODUCT Ozempic 0.25 mg solution for injection in pre-filled pen Ozempic 0.5 mg solution for injection in pre-filled pen Ozempic 1 mg solution for injection in pre-filled pen
Croatian: Ozempic 0,25 mg otopina za injekciju u napunjenoj brizgalici Ozempic 0,5 mg otopina za injekciju u napunjenoj brizgalici Ozempic 1 mg otopina za injekciju u napunjenoj brizgalici
English: Semaglutide is not recommended for use in patients with end-stage renal disease (see section 5.2).
Croatian: Ne preporučuje se primjena semaglutida u bolesnika sa završnim stadijem bolesti bubrega (vidjeti dio
English: Press and hold in the dose button until the dose counter returns to 0.
Croatian: Pritisnite gumb za doziranje i držite ga pritisnutim sve dok se brojčanik doze ne vrati na 0.
English: Ozempic 1 mg solution for injection
Croatian: Ozempic 1 mg otopina za injekciju
English: Start by checking your pen to make sure that it contains Ozempic 1 mg, then look at the illustrations below to get to know the different parts of your pen and needle.
Croatian: Započnite tako što ćete provjeriti Vašu brizgalicu kako biste bili sigurni da sadrži Ozempic 1 mg, zatim pogledajte ilustracije u nastavku da se upoznate s različitim dijelovima Vaše brizgalice i igle.